Theriva Biologics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Theriva Biologics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Theriva Biologics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$55K, a 96% increase year-over-year.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $625K.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.93M, a 103% decline from 2021.
  • Theriva Biologics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $74M, a 2103% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $625K +$2.56M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$1.93M -$75.9M -103% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $74M +$70.6M +2103% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $3.36M +$3.36M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $0 -$29.1M -100% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $29.1M +$10.6M +57.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 $18.5M -$8.23M -30.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $26.7M -$16M -37.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-22
2015 $42.7M +$23.7M +124% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-22
2014 $19M +$6.6M +53.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $12.4M +$224K +1.84% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-10
2012 $12.2M +$5.22M +74.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $6.98M +$5.97M +588% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-16
2010 $1.01M Jan 1, 2010 Dec 31, 2010 10-K/A 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.